Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery

Exclusion Criteria

• •Subjects presenting with ASA Physical Status Classification System Classes III or higher.
• •Pregnant, lactating, or plans to become pregnant during study participation.
• •Known hypersensitivity or allergy to tumescent anesthetic (lidocaine/ epinephrine).
• •Known hypersensitivity or allergy to ibuprofen or other NSAIDS.
• •Active systemic or local skin disease that may alter wound healing.
• •Significant or uncontrolled medical condition that in the opinion of the investigator participation in the study may compromise the patient's health.
• •History of autoimmune disease (excluding Hashimoto's thyroiditis).
• •Known susceptibility to keloid formation or hypertrophic scarring.
• •Cancerous or pre-cancerous lesions in the area to be treated.
• •Possesses a surgically implanted electronic device (i.e. pacemaker).
• •Serious mental health illness such as dementia or schizophrenia; psychiatric hospitalization in the past two years.
• •Participation in any other investigational study within 30 days prior to consent and throughout study participation.
• •Subject who, in the opinion of the investigator, is not an appropriate candidate for the study.
• •Subject who has had a prior facelift, neck lift, or Renuvion treatment in the face/neck area